share_log

艾美疫苗：(經修訂) 截至二零二四年一月三十一日止之股份發行人的證券變動月報表

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

香港交易所 ·  Apr 3 04:48
Summary by Moomoo AI
艾美疫苗股份有限公司於2024年1月31日的證券變動月報表顯示，公司的H股和內資股股份數量在本月內無增減，分別維持在492,173,711股和718,888,888股。該報表於2024年4月3日重新提交給香港交易及結算所有限公司。此外，公司首次公開發售前的僱員股份激勵計劃下，本月底結存的股份期權數目為10,920,000，且本月內無新股份發行。艾美疫苗確認所有相關的上市條件已經履行，並且所有必要文件已正式存檔。
艾美疫苗股份有限公司於2024年1月31日的證券變動月報表顯示，公司的H股和內資股股份數量在本月內無增減，分別維持在492,173,711股和718,888,888股。該報表於2024年4月3日重新提交給香港交易及結算所有限公司。此外，公司首次公開發售前的僱員股份激勵計劃下，本月底結存的股份期權數目為10,920,000，且本月內無新股份發行。艾美疫苗確認所有相關的上市條件已經履行，並且所有必要文件已正式存檔。
EME VACCINES CO., LTD. SECURITIES EXCHANGE REPORT DATED JANUARY 31, 2024 SHOWED THAT THE COMPANY'S NUMBER OF H SHARES AND INWARD SHARES INCREASED UNCHANGED DURING THE MONTH, REMAINING AT 492,173,711 SHARES AND 718,888,888 SHARES, RESPECTIVELY. The report was resubmitted to Hong Kong Trading and Settlement Limited on 3 April 2024. In addition, under the Company's Employee Stock Incentive Program prior to its initial public offering, the number of outstanding share options at the end of the month was 10,920,000 and no new shares were issued during the month. AMIE VACCINES CONFIRMS THAT ALL RELEVANT LISTING CONDITIONS HAVE BEEN MET AND ALL NECESSARY DOCUMENTS HAVE BEEN OFFICIALLY ARCHIVED.
EME VACCINES CO., LTD. SECURITIES EXCHANGE REPORT DATED JANUARY 31, 2024 SHOWED THAT THE COMPANY'S NUMBER OF H SHARES AND INWARD SHARES INCREASED UNCHANGED DURING THE MONTH, REMAINING AT 492,173,711 SHARES AND 718,888,888 SHARES, RESPECTIVELY. The report was resubmitted to Hong Kong Trading and Settlement Limited on 3 April 2024. In addition, under the Company's Employee Stock Incentive Program prior to its initial public offering, the number of outstanding share options at the end of the month was 10,920,000 and no new shares were issued during the month. AMIE VACCINES CONFIRMS THAT ALL RELEVANT LISTING CONDITIONS HAVE BEEN MET AND ALL NECESSARY DOCUMENTS HAVE BEEN OFFICIALLY ARCHIVED.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more